Produktname:5,7-dichloro-3-isopropylpyrazolo[1,5-a]pyrimidine

IUPAC Name:5,7-dichloro-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidine

CAS:771510-32-8
Molekulare Formel:C9H9Cl2N3
Reinheit:95%+
Katalognummer:CM151764
Molekulargewicht:230.09

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM151764-100mg in stock Ūdž
CM151764-250mg in stock ǫƴ
CM151764-1g in stock ŸdžŸ
CM151764-5g in stock ƐŪǫ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:771510-32-8
Molekulare Formel:C9H9Cl2N3
Schmelzpunkt:-
SMILES-Code:CC(C)C1=C2N=C(Cl)C=C(Cl)N2N=C1
Dichte:
Katalognummer:CM151764
Molekulargewicht:230.09
Siedepunkt:
Mdl-Nr.:MFCD12923044
Lagerung:Store at 2-8°C.

Category Infos

Pyrazolopyrimidines
Pyrazolopyrimidine scaffolds are one of the most important heterocyclic compounds in drug discovery. This scaffold has various biological activities, among which anticancer is an important one.

Column Infos

Samuraciclib
Carrick Therapeutics’ Phase 2 Clinical Trial of Samuraciclib combined with Fulvestrant has dosed its first patient. The study targets patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer. Samuraciclib is a selective oral, first-in-class inhibitor of CDK7. It is involved in the regulation of cancer-causing genes, promotion of uncontrolled cell cycle progression, and increase in resistance to anti-hormone therapy. The comb previously receives the Fast Track Designation from the U.S. FDA.

Related Products